October 25, 2018 review Open access Systemic immunoglobulin light chain amyloidosis Nature Reviews Disease Primers DOI: 10.1038/s41572-018-0034-3 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 10 stored of 573 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA 2023 Annals of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 13 citations Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis 2023 Hematology review Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 13 citations Health‐related quality of life in patients with light chain amyloidosis treated with bortezomib, cyclophosphamide, and dexamethasone ± daratumumab: Results from the ANDROMEDA study 2022 American Journal of Hematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 10 citations Additional file 6 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS 2022 Figshare dataset Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 0 citations Additional file 4 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS 2022 Figshare dataset Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 0 citations Additional file 5 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS 2022 Figshare dataset Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 0 citations Additional file 3 of A stepwise data interpretation process for renal amyloidosis typing by LMD-MS 2022 Figshare dataset Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 0 citations Population Pharmacokinetics and Exposure‐Response Modeling of Daratumumab Subcutaneous Administration in Patients With Light‐Chain Amyloidosis 2021 The Journal of Clinical Pharmacology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access 10 citations Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis 2021 New England Journal of Medicine article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes Open access cited by 1 patent 701 citations Diagnostic delay and characterization of the clinical prodrome in AL amyloidosis among 1523 US adults diagnosed between 2001 and 2019 2021 European Journal Of Haematology article Biochemistry, Genetics and Molecular Biology Amyloidosis: Diagnosis, Treatment, Outcomes cited by 2 patents 53 citations 10 results References 0